Cold Sore Treatment Online in California

Yes. California Business and Professions Code Section 2290.5 permits California-licensed physicians to treat recurrent orolabial herpes by synchronous video visit. The Medical Board of California holds telehealth physicians to the same standard of care as in-person physicians. For adults with a history of cold sores and classic prodrome symptoms, telehealth antiviral prescribing is appropriate. Self pay is $49. Aetna is in-network as of April 30, 2026.

Per the CDC STI Treatment Guidelines 2021, valacyclovir 2 g twice daily × 1 day (started at first prodrome) is FDA-approved for orolabial herpes and significantly reduces healing time. Acyclovir 400 mg 5× daily × 5 days is an equally effective alternative. Antivirals work best when started within the first 24–72 hours of prodrome symptoms — before blisters fully form.

Cold sores affect approximately 67% of adults under age 50 globally per the CDC. In California with approximately 39 million residents, an estimated 20–25 million Californians carry HSV-1. Recurrences are triggered by sun exposure, stress, illness, and immunosuppression — all common in California's climate and lifestyle.

With a GoodRx coupon at goodrx.com, valacyclovir 1g costs approximately $26.19 for 30 tablets and $37.67 for 90 tablets (500mg) as of May 2026. The 2-dose episodic regimen (valacyclovir 2 g × 2 doses, 12 hours apart) requires approximately 4 × 1g tablets total — approximately $3–$5 per episode. Prescription costs are separate from the TeleDirectMD $49 visit fee.

California Insurance Code §10123.85 (AB 744, 2019) requires commercial health plans to reimburse telehealth on the same basis as in-person services when TeleDirectMD is in-network. Aetna (active April 30, 2026) and UnitedHealthcare Commercial (approved May 29, 2026) are in-network in California.

Aetna became in-network for TeleDirectMD in California effective April 30, 2026. Verify plan eligibility with Aetna before your visit. Self pay ($49) is available regardless of insurance. See all insurance options.

TeleDirectMD is not currently enrolled as a Medi-Cal rendering provider. California DHCS confirms Medi-Cal covers telehealth for enrolled providers. If you have Medi-Cal, use the $49 self-pay option or seek a Medi-Cal-enrolled telehealth provider.

Yes. HSV-1 can spread to the eye through autoinoculation (touching a cold sore and then touching the eye) — causing herpes simplex keratitis, a serious condition that requires urgent ophthalmology evaluation. HSV can also spread to the fingers (herpetic whitlow) or genitals (through oral-genital contact). TeleDirectMD does not manage HSV keratitis or CNS involvement — these require immediate in-person specialist care.

No. California B&P Code §2290.5 does not require a prior in-person visit before telehealth services. For patients with recurrent cold sores and a clear history, antiviral treatment can be prescribed through a video visit.

Seek urgent in-person evaluation if: cold sores are near the eye (possible herpes keratitis — can threaten vision); you have systemic fever or very severe illness; cold sores occur in a newborn or young infant; you are severely immunocompromised and sores are spreading or non-healing; or this is a first episode with very severe symptoms. Planned Parenthood California and urgent care facilities provide in-person evaluation across the state.

California requires all prescriptions to be issued electronically under Assembly Bill 2789 (effective January 1, 2022). If valacyclovir or acyclovir is appropriate, TeleDirectMD sends an e-prescription to your chosen California pharmacy during or after your visit — most pharmacies fill within 1–4 hours. These antivirals are not controlled substances.

Yes. For patients with frequent cold sore recurrences (6 or more per year), daily suppressive therapy with valacyclovir 500 mg once daily reduces recurrence frequency by approximately 50% per the CDC. TeleDirectMD can prescribe suppressive antiviral therapy for appropriate patients after evaluating recurrence frequency and contraindications.